Also trades as: NVV1.F (FSX) · $vol 0M
NVAX NASDAQ
Novavax, Inc.
1W: -12.3%
1M: -7.2%
3M: +36.5%
YTD: +40.5%
1Y: +17.6%
3Y: +55.8%
5Y: -93.8%
$10.02
+0.62 (+6.60%)
Weekly Expected Move ±16.8%
$6
$8
$10
$11
$13
Credit Risk of going bust: higher than 66% of companies Debt: 15.2% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.23 (down 98%), Novavax, Inc. would be worth roughly what it owes.
Total debt $295.6M against a stock market value of $1.65B.
Distance to default 3.70 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $144.9M (short-term plus half of long-term), stock volatility 69.0%; Altman Z'' -14.52. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.23 (down 98%), Novavax, Inc. would be worth roughly what it owes.
Total debt $295.6M against a stock market value of $1.65B.
Distance to default 3.70 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $144.9M (short-term plus half of long-term), stock volatility 69.0%; Altman Z'' -14.52. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
-0.30
Neutral
0 bullish
2 neutral
1 bearish
Articles (7d)
3
Daily Sentiment (7 Days)
Articles (100)
Novavax (NVAX) Stock Falls Amid Market Uptick: What Investors Need to Know
Biogen (BIIB) Surges 5.3%: Is This an Indication of Further Gains?
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
Novavax (NVAX) Stock Declines While Market Improves: Some Information for Investors
Is Novavax (NVAX) Expensive Or Cheap As Investors Reassess Vaccine Risk? - Simply Wall Street
Discipline and Rules-Based Execution in NVAX Response - Stock Traders Daily
Novavax, Ocular Therapeutix, and QuidelOrtho Shares Plummet, What You Need To Know - Yahoo Finance
Novavax, Ocular Therapeutix, and QuidelOrtho Shares Plummet, What You Need To Know
Moderna Stock Slumps, but It’s Too Early to Panic
Novavax, Ocular Therapeutix, and QuidelOrtho Shares Plummet, What You Need To Know - StockStory
Novavax Plunges 12% as Selloff Hits Vaccine Makers; Moderna Tumbles 10%, Pfizer Holds Steady
Novavax (NVAX) Institutional Ownership 2026 - MarketBeat
NVAX Oct 2026 14.500 call (NVAX261016C00014500) Interactive Stock Chart - Yahoo! Finance Canada
NVAX Oct 2026 11.000 put (NVAX261023P00011000) Stock Historical Prices & Data - Yahoo! Finance Canada
INO, MRNA, NVAX, EBS Jump Overnight: Trump Promises Full Hantavirus Report As Deadly Outbreak Sparks Vaccine Rally - Stocktwits
NVAX Oct 2026 9.000 call (NVAX261023C00009000) Stock Price, News, Quote & History - Yahoo! Finance Canada
NVAX Oct 2026 26.000 call (NVAX261023C00026000) Stock Price, News, Quote & History - Yahoo! Finance Canada
NVAX Oct 2026 10.500 put (NVAX261023P00010500) Interactive Stock Chart - Yahoo! Finance Canada
NVAX Oct 2026 10.500 put (NVAX261023P00010500) Stock Historical Prices & Data - Yahoo! Finance Canada
NVAX Oct 2026 10.500 put (NVAX261023P00010500) Stock Price, News, Quote & History - Yahoo! Finance Canada
NVAX Nov 2026 9.000 call (NVAX261113C00009000) Stock Historical Prices & Data - Yahoo! Finance Canada
SMR Stock Falls Ahead Of Q4 Earnings: AI Power Hype Faces Reality Check - Stocktwits
Lobbying Update: $120,000 of NOVAVAX INC lobbying was just disclosed - Quiver Quantitative
NVAX, EBS, ARCT, MRNA Rally After Russia Plague Lab Worker's Death: Retail Traders Eye 'Contract Awards' - Stocktwits
Novavax (NVAX) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance
Novavax (NVAX) Increases Despite Market Slip: Here's What You Need to Know
Novavax (NVAX) Increases Despite Market Slip: Here's What You Need to Know
Moderna Stock Soared 14% as NIH Plans COVID-Style Push for Cancer Vaccines
Vaccine Stocks Rally on Reports of U.S.-led Push for Cancer Vaccines
Vaccine Stocks Rally on Reports of U.S.-led Push for Cancer Vaccines
Novavax (NVAX) Could Be 82% Overvalued On Plague Headlines And Pfizer Deal Focus - Simply Wall Street
Novavax (NVAX) Could Be 82% Overvalued On Plague Headlines And Pfizer Deal Focus - Simply Wall Street
NOVAVAX INC (NVAX) Stock Chart - ChartMill
BNTX, NVAX, MRNA Lead Vaccine Rally After Report Of An NIH Cancer-Vaccine Push
Sector Update: Healthcare Stocks Gain Late Afternoon
Novavax Swings To Profit In Q4 Fueled By Nuvaxovid-Linked Revenue - Stocktwits
Novavax Soars 16%, Moderna Surges 11%, Merck Climbs 3% as Biotech Rallies
Sector Update: Healthcare Stocks Gain Friday Afternoon
NVAX Stock Grinds Higher As Traders Watch Volatile Rebound - Timothy Sykes
Moderna stock hits 4-year high on planned national cancer vaccine effort
NVAX Oct 2026 12.000 put (NVAX261009P00012000) Stock Price, News, Quote & History - Yahoo! Finance Canada
NVAX Oct 2026 13.500 call (NVAX261030C00013500) Interactive Stock Chart - Yahoo! Finance Canada
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know - Yahoo! Finance Canada
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know
NVAX Oct 2026 12.500 put (NVAX261009P00012500) Stock Price, News, Quote & History - Yahoo! Finance Canada
Novavax Q4 Earnings Preview: Wall Street Expects Wider Losses Amid Diversification Efforts - Stocktwits
Novavax: Sell The False Plague Breakout (NASDAQ:NVAX) - Seeking Alpha
Novavax (NVAX) Stock Could Be Above Fair Value As Plague Fears Fade - Yahoo Finance
Novavax (NVAX) Stock Could Be Above Fair Value As Plague Fears Fade
NVAX Stock Rises Ahead Of Q2 Earnings As Focus Shifts To Licensing Deals - Stocktwits
Should Novavax’s Headline-Driven Volatility Around Russia Health Scare Require Action From NVAX Investors? - Yahoo Finance
Should Novavax’s Headline-Driven Volatility Around Russia Health Scare Require Action From NVAX Investors?
Novavax Stock Hits Over 1-Year High: Is Sanofi’s Flu-COVID Shot The Post-Pandemic Growth Driver? - Stocktwits
NVAX Stock Rises Overnight Ahead Of Q4 Print With Pfizer Tailwinds — Analyst Warns Of 20% Crash - Stocktwits
Novavax and Moderna Shares Fall as Citi Assesses Vaccine Sector Volatility
Novavax and Moderna Shares Fall as Citi Assesses Vaccine Sector Volatility - Yahoo Finance
Pandemic Panic Is Back on Wall Street. What to Know About the Russian Plague Scare.
Novavax (NVAX) Stock Sinks As Market Gains: Here's Why - Yahoo Finance
Novavax (NVAX) Stock Sinks As Market Gains: Here's Why
Novavax (NVAX) Stock Sinks As Market Gains: Here's Why
Novavax Sinks 12% as WHO Calls Plague Risk “Very Low”
NVAX Stock Slides As Momentum Traders Refocus On Fundamentals - StocksToTrade
Novavax, Moderna stocks fall after WHO calls plague risk 'low'
Novavax Stock Falls Back: What's Going On? - Benzinga
Novavax Pulls Back From Plague-Scare Spike as Officials Call Risk Low; Moderna and Pfizer Inch Higher
Novavax, Moderna cool as WHO downplays plague-related death in Russia
Novavax (NVAX) Surges 20.1%: Is This an Indication of Further Gains?
Novavax (NVAX) Surges 20.1%: Is This an Indication of Further Gains?
Novavax (NVAX) Stock Looks Fully Priced On Its Current Sales Base - Simply Wall Street
NVAX, EBS, ARCT, MRNA Rally After Russia Plague Lab Worker's Death: Retail Traders Eye 'Contract Awards'
Dow, S&P 500, Nasdaq Futures Edge Higher After Nasdaq Climbs To Record High: SPCX, USAR, CEG, NVAX Stocks In Focus - Stocktwits
NVAX Stock Outruns Moderna As Vaxcyte’s Shot Clears A Late-Stage Test
Novavax jumps as investors revisit multi-market vaccine approvals and royalty upside - Quiver Quantitative
Why is Novavax stock surging today? - Investing.com
Novavax Shorts on Edge as Russia Plague Fears Spread - Benzinga
Novavax Soars 22% as Sanofi Carries Nuvaxovid Into Vaccination Season; Moderna Climbs 8%, BioNTech Ticks Up - 24/7 Wall St.
NVAX Stock Outruns Moderna As Vaxcyte’s Shot Clears A Late-Stage Test - Stocktwits
Novavax, Inc. (NVV1.F) Stock Price, News, Quote & History - Yahoo! Finance Canada
Novavax, Inc. (NVAX) stock price, news, quote and history - Yahoo Finance UK
Novavax, Inc. (NVAX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Novavax Stock Price Forecast. Should You Buy NVAX? - StockInvest.us
Short Interest Alert: Most and least shorted sub-$2B healthcare stocks in Sep. 2026
3 Overrated Stocks We Approach with Caution
Novavax (NVAX) Rises As Market Takes a Dip: Key Facts
Novavax (NVAX) Rises As Market Takes a Dip: Key Facts
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Novavax (NVAX) Rises As Market Takes a Dip: Key Facts - Yahoo Finance
3 Volatile Stocks with Questionable Fundamentals
Novavax (NVAX) Beats Stock Market Upswing: What Investors Need to Know
Novavax (NVAX) Beats Stock Market Upswing: What Investors Need to Know
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It - Eastern Progress
Novavax (NVAX) Soars 7.0%: Is Further Upside Left in the Stock?
Novavax (NVAX) Soars 7.0%: Is Further Upside Left in the Stock?
Moderna Climbs 6% as Cancer Vaccine Trade Extends a 137% Month; BioNTech and Novavax Edge Higher
HHS to launch autism research initiative utilizing AI: report
Novavax (NVAX) Could Be 32% Above Fair Value On Medicare Policy Fears